Edwards Lifesciences Financials

EW Stock  USD 95.15  1.73  1.85%   
Based on the key indicators related to Edwards Lifesciences' liquidity, profitability, solvency, and operating efficiency, Edwards Lifesciences Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Edwards Lifesciences' Liabilities And Stockholders Equity is fairly stable compared to the past year. Inventory is likely to climb to about 1.2 B in 2024, whereas Good Will is likely to drop slightly above 688.6 M in 2024. Key indicators impacting Edwards Lifesciences' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.250.2335
Notably Up
Slightly volatile
Return On Assets0.0780.1498
Way Down
Pretty Stable
Return On Equity0.110.2109
Way Down
Very volatile
Debt Equity Ratio0.09930.1045
Notably Down
Slightly volatile
Operating Income1.6 B1.5 B
Sufficiently Up
Slightly volatile
Current Ratio2.333.376
Way Down
Slightly volatile
The financial analysis of Edwards Lifesciences is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Edwards Lifesciences includes many different criteria found on its balance sheet. For example, investors should never minimize Edwards Lifesciences' ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Edwards Lifesciences' cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Edwards Lifesciences.

Cash And Equivalents

1.01 Billion

With this module, you can analyze Edwards financials for your investing period. You should be able to track the changes in Edwards Lifesciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Edwards Lifesciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Edwards Lifesciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Edwards Lifesciences' assets may result in an increase in income on the income statement.
Evaluating Edwards Lifesciences' financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Edwards Lifesciences' profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Edwards Lifesciences' relative financial performance

Chance Of Distress

Less than 5

 
100  
 
Zero
Very Low
Edwards Lifesciences Corp has less than 5 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Edwards Lifesciences stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Edwards Lifesciences' odds of distress score SHOULD NOT be confused with the real chance of Edwards Lifesciences Corp filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Edwards is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Edwards Lifesciences' liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Edwards Lifesciences' official financial statements usually reflect Edwards Lifesciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Edwards Lifesciences Corp. For example, before you start analyzing numbers published by Edwards accountants, it's critical to develop an understanding of what Edwards Lifesciences' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Edwards Lifesciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Edwards Lifesciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Edwards Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Edwards Lifesciences Corp. Please utilize our Beneish M Score to check the likelihood of Edwards Lifesciences' management manipulating its earnings.

Edwards Lifesciences Company Summary

Edwards Lifesciences competes with EUDA Health, Spectral, Cigna Corp, Definitive Healthcare, and Guardant Health. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 15700 people.
Foreign Associate
  Mexico
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
CIK Number0001099800
ISINUS28176E1082
CUSIP28176E108
RegionNorth America
LocationCalifornia; U.S.A
Business AddressOne Edwards Way,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.edwards.com
Phone949 250 2500
CurrencyUSD - US Dollar
You should never invest in Edwards Lifesciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Edwards Stock, because this is throwing your money away. Analyzing the key information contained in Edwards Lifesciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Edwards Lifesciences Key Financial Ratios

Generally speaking, Edwards Lifesciences' financial ratios allow both analysts and investors to convert raw data from Edwards Lifesciences' financial statements into concise, actionable information that can be used to evaluate the performance of Edwards Lifesciences over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Edwards Lifesciences Corp reports annually and quarterly.

Edwards Lifesciences Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets6.5B7.2B8.5B8.3B9.4B9.8B
Other Current Liab6.4M39.3M3.9M311M15.2M14.4M
Retained Earnings3.7B4.6B6.1B7.6B9.0B9.4B
Net Receivables599.1M602.8M664.9M699.1M836.9M878.7M
Good Will1.2B1.2B1.2B1.2B1.3B688.6M
Inventory640.9M802.3M726.7M875.5M1.2B1.2B
Other Current Assets168M208.2M237.1M195.9M239.3M251.3M
Total Liab2.3B2.7B2.7B2.5B2.6B1.4B
Total Current Assets3.0B3.1B3.2B3.1B4.0B4.2B
Other Liab784.1M1.1B969.6M797.6M917.2M963.1M
Net Debt(500.3M)(488.3M)(172.5M)(77.7M)(449.1M)(426.6M)
Accounts Payable180.4M196.5M204.5M201.9M201.4M139.5M
Cash1.2B1.2B862.8M769M1.1B1.2B
Other Assets274M1.2B357.5M783.1M900.6M945.6M
Long Term Debt594.4M595M595.7M596.3M597M425.6M
Short Term Debt598M0.025.5M27.2M24.9M23.7M
Intangible Assets336.5M331.4M323.6M285.2M428.4M449.8M
Common Stock218.1M636.4M642M646.3M650.5M683.0M
Treasury Stock(1.0B)(1.3B)(1.9B)(2.4B)(2.2B)(2.1B)
Net Tangible Assets2.9B3.4B4.3B4.4B5.0B5.3B
Capital Surpluse1.6B1.4B1.7B2.0B2.3B1.2B

Edwards Lifesciences Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Edwards Lifesciences' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense20.7M15.8M18.4M19.2M17.6M10.6M
Total Revenue4.3B4.4B5.2B5.4B6.0B6.3B
Gross Profit3.2B3.3B4.0B4.3B4.6B4.9B
Operating Income1.1B1.6B1.3B1.7B1.5B1.6B
Ebit1.1B1.6B1.3B1.7B1.5B1.6B
Research Development752.7M760.7M903.1M945.2M1.1B1.1B
Ebitda1.3B1.7B1.5B1.8B1.5B1.6B
Cost Of Revenue1.1B1.1B1.2B1.1B1.4B697.9M
Income Before Tax1.2B916.7M1.7B1.8B1.6B1.7B
Net Income1.0B823.4M1.5B1.5B1.4B1.5B
Income Tax Expense119.6M93.3M198.9M245.5M198.7M113.1M
Non Recurring98M405.4M20.6M76.5M88.0M92.4M
Tax Provision119.6M93.3M198.9M245.5M207.6M201.8M
Net Interest Income11.5M7.6M(1M)16.3M40.7M42.7M
Interest Income32.2M7.6M1M16.3M67.2M70.6M

Edwards Lifesciences Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Edwards Lifesciences Corp. It measures of how well Edwards is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Edwards Lifesciences brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Edwards had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Edwards Lifesciences has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Change To Inventory(105.4M)(120.6M)19M(213.4M)(289M)(274.6M)
Free Cash Flow901M647M1.4B953.4M629.5M444.3M
Depreciation89.3M107.2M134.8M139.6M144.9M81.8M
Other Non Cash Items154.1M38.3M(119M)105.8M10.5M10.0M
Capital Expenditures278.4M407.3M329.8M264.8M266.3M146.6M
Net Income1.0B823.4M1.5B1.5B1.4B1.5B
Change In Cash465M15.8M(332.8M)(94.8M)375.4M394.2M
End Period Cash Flow1.2B1.2B867.4M772.6M1.1B1.2B
Dividends Paid18.9M(140.5M)(158.6M)(146.4M)(169.9M)(161.4M)
Investments(158.2M)(101.7M)(1.3B)252.3M254.4M267.1M
Change Receivables(88M)41.9M(91.1M)(84.1M)(75.7M)(71.9M)
Net Borrowings(10M)(800K)(1.8M)(200K)(180K)(171K)
Change To Netincome198.2M53.3M(79.6M)(49.1M)(56.5M)(53.6M)

Edwards Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Edwards Lifesciences competition to find correlations between indicators driving Edwards Lifesciences's intrinsic value. More Info.
Edwards Lifesciences Corp is rated # 2 in price to earning category among related companies. It is rated below average in shares owned by insiders category among related companies making about  0.03  of Shares Owned By Insiders per Price To Earning. The ratio of Price To Earning to Shares Owned By Insiders for Edwards Lifesciences Corp is roughly  39.01 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Edwards Lifesciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Edwards Lifesciences' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Edwards Lifesciences' earnings, one of the primary drivers of an investment's value.

Edwards Lifesciences Corp Systematic Risk

Edwards Lifesciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Edwards Lifesciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Edwards Lifesciences Corp correlated with the market. If Beta is less than 0 Edwards Lifesciences generally moves in the opposite direction as compared to the market. If Edwards Lifesciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Edwards Lifesciences Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Edwards Lifesciences is generally in the same direction as the market. If Beta > 1 Edwards Lifesciences moves generally in the same direction as, but more than the movement of the benchmark.

About Edwards Lifesciences Financials

What exactly are Edwards Lifesciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Edwards Lifesciences' income statement, its balance sheet, and the statement of cash flows. Potential Edwards Lifesciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Edwards Lifesciences investors may use each financial statement separately, they are all related. The changes in Edwards Lifesciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Edwards Lifesciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Edwards Lifesciences Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Edwards Lifesciences is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Edwards has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Edwards Lifesciences' financials are consistent with your investment objective using the following steps:
  • Review Edwards Lifesciences' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Edwards Lifesciences' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Edwards Lifesciences' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Edwards Lifesciences' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Edwards Lifesciences Thematic Clasifications

Edwards Lifesciences Corp is part of several thematic ideas from Obamacare Repeal to Medical Equipment. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Edwards Lifesciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Edwards Lifesciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Edwards Lifesciences growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(5.14)

At this time, Edwards Lifesciences' Price Earnings To Growth Ratio is fairly stable compared to the past year.

Edwards Lifesciences March 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Edwards Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Edwards Lifesciences Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Edwards Lifesciences Corp based on widely used predictive technical indicators. In general, we focus on analyzing Edwards Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Edwards Lifesciences's daily price indicators and compare them against related drivers.
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.3
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.